Nurix Therapeutics, Inc. (NRIX)
NASDAQ: NRIX · Real-Time Price · USD
15.50
+0.40 (2.65%)
At close: Mar 9, 2026, 4:00 PM EDT
15.68
+0.18 (1.19%)
After-hours: Mar 9, 2026, 5:14 PM EDT

Nurix Therapeutics Cash Flow Statement

Millions USD. Fiscal year is Dec - Nov.
Fiscal Year
FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 2020 - 2018
Period Ending
Nov '25 Nov '24 Nov '23 Nov '22 Nov '21 2020 - 2018
Net Income
-264.46-193.57-143.95-180.36-117.19
Upgrade
Depreciation & Amortization
18.2615.1312.259.615.28
Upgrade
Other Amortization
0.61.31.41.20.8
Upgrade
Loss (Gain) From Sale of Assets
0.090.030.560.010.13
Upgrade
Loss (Gain) From Sale of Investments
-10.32-11.29-5.420.431.71
Upgrade
Stock-Based Compensation
37.9733.9333.6728.1315.8
Upgrade
Other Operating Activities
-0.29-0.2-
Upgrade
Change in Accounts Receivable
---6-6
Upgrade
Change in Accounts Payable
-0.635.211.610.091.59
Upgrade
Change in Unearned Revenue
-36.98-28.5519.51-26.6314.25
Upgrade
Change in Income Taxes
----3.64
Upgrade
Change in Other Net Operating Assets
6.014.94-1.011.52-4.37
Upgrade
Operating Cash Flow
-249.47-172.58-81.37-159.81-84.37
Upgrade
Capital Expenditures
-14-9.27-8.4-12.24-5.66
Upgrade
Investment in Securities
161.86-248.4476.739.44-102.59
Upgrade
Investing Cash Flow
147.85-257.7168.327.2-108.25
Upgrade
Issuance of Common Stock
238.64485.683.2222.43164.13
Upgrade
Repurchase of Common Stock
--0.02---
Upgrade
Other Financing Activities
---94.76-10.24
Upgrade
Financing Cash Flow
238.64485.673.22117.19153.88
Upgrade
Net Cash Flow
137.0355.37-9.85-15.42-38.73
Upgrade
Free Cash Flow
-263.47-181.86-89.77-172.05-90.03
Upgrade
Free Cash Flow Margin
-313.73%-333.38%-116.60%-445.42%-302.61%
Upgrade
Free Cash Flow Per Share
-3.04-2.71-1.65-3.54-2.10
Upgrade
Cash Income Tax Paid
----0.48
Upgrade
Levered Free Cash Flow
-143.99-85.9-41.93-79.42-37.7
Upgrade
Unlevered Free Cash Flow
-143.99-85.9-41.93-79.42-37.7
Upgrade
Change in Working Capital
-31.6-18.420.12-19.029.11
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.